|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030956,
umls-concept:C0038952,
umls-concept:C0178539,
umls-concept:C0871261,
umls-concept:C0877373,
umls-concept:C1516213,
umls-concept:C1519885,
umls-concept:C1527178,
umls-concept:C1704632,
umls-concept:C1705938,
umls-concept:C1706817,
umls-concept:C2347662,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-2-11
|
|
pubmed:abstractText |
The aim of this study is to find a laboratory marker for overall survival in advanced cancer patients who were vaccinated with peptides based on pre-existing, peptide-specific CTL precursors in the circulation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:GouharaRumiR,
pubmed-author:HashimotoTakashiT,
pubmed-author:ItohKyogoK,
pubmed-author:KamuraToshiharuT,
pubmed-author:KatagiriKazukoK,
pubmed-author:MineTakashiT,
pubmed-author:NoguchiMasanoriM,
pubmed-author:RikimaruTouruT,
pubmed-author:SasatomiTeruoT,
pubmed-author:SatoYujiY,
pubmed-author:ShichijoShigekiS,
pubmed-author:ShirouzuKazuoK,
pubmed-author:ShomuraHirokiH,
pubmed-author:TanakaShokoS,
pubmed-author:TodoSatoruS,
pubmed-author:TsudaNaotakeN,
pubmed-author:YamadaAkiraA,
pubmed-author:YamanaHideakiH
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
929-37
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:14871969-Adult,
pubmed-meshheading:14871969-Aged,
pubmed-meshheading:14871969-Aged, 80 and over,
pubmed-meshheading:14871969-Antibody Formation,
pubmed-meshheading:14871969-Cancer Vaccines,
pubmed-meshheading:14871969-Chromium Radioisotopes,
pubmed-meshheading:14871969-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:14871969-Female,
pubmed-meshheading:14871969-Humans,
pubmed-meshheading:14871969-Immunoglobulin G,
pubmed-meshheading:14871969-Interferon-gamma,
pubmed-meshheading:14871969-Male,
pubmed-meshheading:14871969-Middle Aged,
pubmed-meshheading:14871969-Peptides,
pubmed-meshheading:14871969-Prognosis,
pubmed-meshheading:14871969-Time Factors,
pubmed-meshheading:14871969-Treatment Outcome,
pubmed-meshheading:14871969-Tumor Markers, Biological
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.
|
|
pubmed:affiliation |
Department of Immunology, Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka, Kurume 830-0011, Japan. mine@med.kurume-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
